CrowdStrike is back near highs despite crashing in July. Why Raymond James' David Cox calls it "immediately suspicious." ...

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In this article, we are going ...

Stocks have gotten off to a mixed start in 2025, but a third straight year of gains isn’t out of the question.

'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, ...

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

CNBC's Jim Cramer examined Monday's market action, saying the tech-heavy Nasdaq failed to rally largely due to a unique ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

CNBC’s Jim Cramer on Friday told investors why he thinks it’s a good time to buy sports betting platform DraftKings, whose ...

CNBC's Jim Cramer on Friday previewed next week's top market-moving events, highlighting earnings reports from several major ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

We recently published a list of 10 Jim Cramer Stocks to Watch in 2025. In this article, we are going to take a look at where ...

Jim Cramer urged investors to consider NVIDIA Corp.'s recent stock decline as a buying opportunity, despite the company's ...